Mehdi Salar Amoli

Mr. Mehdi Salar Amoli

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2021 in Polymers
Verified
Journal Article
Open access
PDF file
ZNZohreh Mousavi Nejad
Zohreh Mousavi Nejad
AZAli Zamanian
Ali Zamanian
MSMaryam Saeidifar
Maryam Saeidifar
Hamid VanaeiHamid Vanaei
Hamid Vanaei
MAMehdi Salar Amoli
Mehdi Salar Amoli
In this study, two structurally different scaffolds, a polycaprolactone (PCL)/45S5 Bioglass (BG) composite and PCL/hyaluronic acid (HyA) were fabricated by 3D printing technology and were evaluated for the regeneration of dentin and pulp tissues, respectively. Their physicochemical characterization was performed by field emission scanning electron microscopy (FESEM) equipped with energy dispersive spectroscopy (EDS), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), atomic force microscopy (AFM), contact angle, and compressive strength tests. The results indicated that the presence of BG in the PCL/BG scaffolds promoted the mechanical properties, surface roughness, and bioactivity. Besides, a surface treatment of the PCL scaffold with HyA considerably increased the hydrophilicity of the scaffolds which led to an enhancement in cell adhesion. Furthermore, the gene expression results showed a significant increase in expression of odontogenic markers, e.g., dentin sialophosphoprotein (DSPP), osteocalcin (OCN), and dentin matrix protein 1 (DMP-1) in the presence of both PCL/BG and PCL/HyA scaffolds. Moreover, to examine the feasibility of the idea for pulp-dentin complex regeneration, a bilayer PCL/BG-PCL/HyA scaffold was successfully fabricated and characterized by FESEM. Based on these results, it can be concluded that PCL/BG and PCL/HyA scaffolds have great potential for promoting hDPSC adhesion and odontogenic differentiation.

30 December 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMehdi Salar Amoli
Mehdi Salar Amoli
Mostafa EzEldeenMostafa EzEldeen
Mostafa EzEldeen
RJReinhilde Jacobs
Reinhilde Jacobs
Veerle BloemenVeerle Bloemen
Veerle Bloemen
Although current treatments can successfully address a wide range of complications in the dentoalveolar region, they often still suffer from drawbacks and limitations, resulting in sub-optimal treatments for specific problems. In recent decades, significant progress has been made in the field of tissue engineering, aiming at restoring damaged tissues via a regenerative approach. Yet, the translation into a clinical product is still challenging. Novel technologies such as bioprinting have been developed to solve some of the shortcomings faced in traditional tissue engineering approaches. Using automated bioprinting techniques allows for precise placement of cells and biological molecules and for geometrical patient-specific design of produced biological scaffolds. Recently, bioprinting has also been introduced into the field of dentoalveolar tissue engineering. However, the choice of a suitable material to encapsulate cells in the development of so-called bioinks for bioprinting dentoalveolar tissues is still a challenge, considering the heterogeneity of these tissues and the range of properties they possess. This review, therefore, aims to provide an overview of the current state of the art by discussing the progress of the research on materials used for dentoalveolar bioprinting, highlighting the advantages and shortcomings of current approaches and considering opportunities for further research.

2 April 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
MAMehdi Salar Amoli
Mehdi Salar Amoli
RAResmi Anand
Resmi Anand
Mostafa EzEldeenMostafa EzEldeen
Mostafa EzEldeen
Paulo Alexandre AmorimPaulo Alexandre Amorim
Paulo Alexandre Amorim
LGLiesbet Geris
Liesbet Geris
Veerle BloemenVeerle Bloemen
Veerle Bloemen

12 February 2024 in Gels
Verified
Journal Article
Open access
PDF file
MAMehdi Salar Amoli
Mehdi Salar Amoli
RAResmi Anand
Resmi Anand
Mostafa EzEldeenMostafa EzEldeen
Mostafa EzEldeen
LGLiesbet Geris
Liesbet Geris
RJReinhilde Jacobs
Reinhilde Jacobs
Veerle BloemenVeerle Bloemen
Veerle Bloemen
While available treatments have addressed a variety of complications in the dentoalveolar region, associated challenges have resulted in exploration of tissue engineering techniques. Often, scaffold biomaterials with specific properties are required for such strategies to be successful, development of which is an active area of research. This study focuses on the development of a copolymer of poly (N-isopropylacrylamide) (pNIPAM) and chitosan, used for 3D printing of scaffolds for dentoalveolar regeneration. The synthesized material was characterized by Fourier transform infrared spectroscopy, and the possibility of printing was evaluated through various printability tests. The rate of degradation and swelling was analyzed through gravimetry, and surface morphology was characterized by scanning electron microscopy. Viability of dental pulp stem cells seeded on the scaffolds was evaluated by live/dead analysis and DNA quantification. The results demonstrated successful copolymerization, and three formulations among various synthesized formulations were successfully 3D printed. Up to 35% degradability was confirmed within 7 days, and a maximum swelling of approximately 1200% was achieved. Furthermore, initial assessment of cell viability demonstrated biocompatibility of the developed scaffolds. While further studies are required to achieve the tissue engineering goals, the present results tend to indicate that the proposed hydrogel might be a valid candidate for scaffold fabrication serving dentoalveolar tissue engineering through 3D printing.

8 April 2025 in STAR Protocols
Verified
Journal Article
Open access
MAMehdi Salar Amoli
Mehdi Salar Amoli
SRSarah Rezapourdamanab
Sarah Rezapourdamanab
LJLinqi Jin
Linqi Jin
MCMelissa A. Cadena
Melissa A. Cadena
KKKaveeta Kaw
Kaveeta Kaw
Vahid SerpooshanVahid Serpooshan
Vahid Serpooshan
Here, we present a protocol for developing an in vitro 3D model of neuroblastoma through bioprinting, incorporating key components of the tumor microenvironment (TME), including vasculature and cancer cell line spheroids. We describe steps for the preparation, bioprinting, and evaluation of tumor models and their use to assess the impact of TME on solid tumor behavior. We report procedures for bioink preparation, bioprinting, the measurement of mechanical properties and fidelity, as well as the viability of different cell types and their interactions. For complete details on the use and execution of this protocol, please refer to Ning et al.1.

24 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
LJLinqi Jin
Linqi Jin
CPChristian Park
Christian Park
SNSunder Neelakantan
Sunder Neelakantan
SKShweta Karnik
Shweta Karnik
ADArnab Dey
Arnab Dey
Vahid SerpooshanVahid Serpooshan
Vahid Serpooshan
Human heart development depends on tightly coordinated genetic programs and biomechanical cues, yet the underlying cell–microenvironment interactions remain poorly understood because the developing heart is difficult to study in utero and accurate experimental models are lacking. Recent advances in stem cell biology and three-dimensional (3D) bioprinting now allow the construction of human tissue analogues with defined structure and function. Here we show a perfusable 3D bioprinted model of the human embryonic heart tube composed of layered myocardium, cardiac jelly, and endocardium. Human induced pluripotent stem cell–derived cardiomyocytes and endothelial cells are cultured under controlled flow conditions, producing constructs with high cell viability, complete lumen endothelialization, progressive myocardial compaction, and coordinated tissue-level contraction. Single-cell transcriptomic analysis reveals that dynamic flow promotes cardiac maturation and lineage specification. This platform provides a human-relevant model to study early heart development, investigate congenital heart disease mechanisms, and evaluate emerging therapeutic strategies.